PNEUMAGEN
Pneumagen focuses on developing glycan targeted carbohydrate-binding modules (CBMs) as a new universal therapeutic modality for the treatment of respiratory tract infections (RTIs) and cancer. Founded in 2016, the Company is a spin-out from the University of St Andrews in Scotland and has access to world-class scientific expertise and capabilities in glycobiology.
PNEUMAGEN
Industry:
Biotechnology Health Care Wellness
Founded:
2016-01-01
Address:
Saint Andrews, Fife, United Kingdom
Country:
United Kingdom
Website Url:
http://www.pneumagen.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
10.3 M GBP
Similar Organizations
Pandion Therapeutics
Pandion Therapeutics develops innovative modular proteins, antibodies, and bispecifics for autoimmune and inflammatory diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
Scottish Enterprise
Scottish Enterprise investment in Venture Round - Pneumagen
Thairm Bio
Thairm Bio investment in Venture Round - Pneumagen
Thairm Bio
Thairm Bio investment in Venture Round - Pneumagen
Scottish Investment Bank
Scottish Investment Bank investment in Venture Round - Pneumagen
Scottish Investment Bank
Scottish Investment Bank investment in Venture Round - Pneumagen
Thairm Bio
Thairm Bio investment in Venture Round - Pneumagen
Official Site Inspections
http://www.pneumagen.com Semrush global rank: 5.19 M Semrush visits lastest month: 1.56 K
- Host name: server.ncserver.co.uk
- IP address: 62.100.204.187
- Location: United Kingdom
- Latitude: 51.4964
- Longitude: -0.1224
- Timezone: Europe/London
